bioMérieux
Logotype for bioMérieux S.A

bioMérieux (BIM) investor relations material

bioMérieux H2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for bioMérieux S.A
H2 2025 earnings summary27 Feb, 2026

Executive summary

  • Achieved €4,070 million in sales for 2025, representing 6.2% organic growth, outpacing a 1% market increase, with strong contributions from new product launches, acquisitions, and automation initiatives.

  • Contributive EBIT (CEBIT) reached €728 million (17.9% of sales), up 16% organically, driven by operational simplification, innovation, and margin improvement.

  • Free cash flow surged 40% to €462 million, reflecting robust cash generation and disciplined capital allocation.

  • Adjusted EPS increased 9% to €4.64; adjusted net income up 9.4% to €552 million.

  • Significant CSR progress, with a 28–29% reduction in greenhouse gas emissions since 2019, while sales grew 50%.

Financial highlights

  • Gross profit margin improved to 56.7% of sales, up 90 basis points like-for-like, driven by product mix and efficiency gains.

  • EBITDA reached €960 million (23.6% of sales), up 10% organically; adjusted EPS rose 9% to €4.64.

  • Dividend proposed at €0.98 per share, up 9% from the prior year.

  • CapEx at €328–335 million (8–8.2% of sales), focused on manufacturing automation and instrument placement.

  • Net cash position at €108 million at year-end.

Outlook and guidance

  • 2026 organic sales growth expected between 5% and 7%, with CEBIT to increase by at least 10%.

  • Key growth drivers: BIOFIRE® non-respiratory panels (~10%), SPOTFIRE® (40–60%), Microbiology (3–5%), Industrial Applications (7–9%).

  • Respiratory panels expected between -3% and +3%, immunoassays -5% to 0%.

  • Currency effects estimated to negatively impact EBIT/CEBIT by €50–60 million.

  • Strategic plan targets 7% CAGR sales growth and 10% annual CEBIT growth through 2028.

VITEK REVEAL market development challenges
SPOTFIRE's rapid growth: key drivers
China market challenges: mitigation plans
BIOFIRE: What drives 1,800 net installs?
Mitigating FX/tariff impact on 2026 EBIT margin
Immunoassays: Path to stabilize sales in 2026?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next bioMérieux earnings date

Logotype for bioMérieux S.A
Q1 2026 TU23 Apr, 2026
bioMérieux
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next bioMérieux earnings date

Logotype for bioMérieux S.A
Q1 2026 TU23 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

bioMérieux S.A. is a global biotechnology company that specializes in the development, manufacturing, and marketing of in vitro diagnostic solutions for medical and industrial applications. The company’s products include diagnostic tools for infectious diseases, oncology, cardiovascular diseases, and food safety testing. bioMérieux offers a range of systems, reagents, and software designed for microbiology, immunoassays, and molecular biology, helping healthcare providers and laboratories detect pathogens and analyze biological samples. The company also serves industrial markets, providing solutions for food safety, pharmaceutical quality control, and environmental monitoring. The company is headquartered in Marcy-l'Étoile, France, and its shares are listed on Euronext Paris.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage